Troxerutin markets in China strengthened in February as a limited exportable supply and firm overseas demand supported higher offer levels. Early-month inventories remained lean following a strong shipment program, while producers prioritized export commitments, and coastal finishing facilities recalibrated GMP equipment, reducing immediate export surplus. Demand from India and Brazil remained active, with forward bookings and replenishment purchases encouraging suppliers to maintain pricing discipline. Logistics stayed largely stable despite seasonal congestion near Shanghai, and cargo staging was not materially disrupted. Nutraceutical demand continued to underpin the market, as Indian blenders and food-grade formulators secured raw-material coverage, while Brazilian distributors rebuilt inventories. Domestic tablet and topical-gel production remained comparatively stable, and European buyers procured parcels for injectable-grade formulations. Upstream pressure from rising solvent costs and firmer feedstock activity compressed margins and supported partial cost pass-through. By mid-March, sentiment strengthened further as geopolitical tensions involving the United States, Israel, and Iran elevated energy and logistics costs, supporting continued gains.
